KraneShares MSCI All China Health Care Index ETF (KURE)

Description

The investment seeks to track the performance of the MSCI China All Shares Health Care 10/40 Index. The KURE ETF contains 90 constituents. It is focused on blend holdings in the Asia-Pacific region.

Price $18.63 as of 2022-10-20

Cost/Risk/Yield

Dividend yield
Expense ratio0.65%
Average spread0.805%
1Y roundtrip cost1.455%

Historic prices

Total Returns (including dividends)

Monthly returns heatmap

Historical Dividends

Monthly dividend heatmap

Sectors and Top Holdings

Security % Assets
Wuxi Biologics (Cayman) Inc.9.69%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A6.12%
WuXi AppTec Co., Ltd. Class A4.66%
BeiGene, Ltd. Sponsored ADR4.31%
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A4.20%
Aier Eye Hospital Group Co., Ltd. Class A3.51%
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A3.36%
Chongqing Zhifei Biological Products Co., Ltd. Class A2.95%
Innovent Biologics, Inc.2.92%
CSPC Pharmaceutical Group Limited2.59%
Zai Lab Ltd. Sponsored ADR2.19%
Sino Biopharmaceutical Limited2.13%
WuXi AppTec Co., Ltd. Class H1.98%
Pharmaron Beijing Co., Ltd. Class A1.66%
IMEIK Technology Development Co., Ltd. Class A1.56%
Top 15 Weights53.83%

Compare with similar ETFs

Historic volatility

Implied volatility

Put/Call Ratio (option volume)

Put/Call Ratio (open interest)

Volatility Spread

Volatility Skew